Skip to main content
. 2021 Apr 18;38(5):2673–2688. doi: 10.1007/s12325-021-01727-5

Fig. 1.

Fig. 1

Unweighted median platelet count by duration of ITP at romiplostim initiation, from initial dose through the 24-week follow-up period. Table represents the number of patients in each strata at week 0 (romiplostim initiation), week 12, and week 24 of follow-up